Chiron Real Estate Inc. (XRN) - Form 8-K Summary
Business Context and Reporting Period
Chiron Real Estate Inc. filed this Current Report on Form 8-K on May 8, 2026, regarding events occurring on May 6, 2026. The filing details the entry into a Material Definitive Agreement for a private placement of preferred stock and associated investor rights.
Key Financial Metrics and Transaction Terms
- Commitment Amount: Up to $100.0 million in aggregate gross proceeds.
- Security Issued: 1,000,000 shares of 6.00% Series C Convertible Perpetual Preferred Stock.
- Purchase Price: $100.00 per share (Liquidation Preference).
- Dividend Rate: Initial rate of 6.00% per annum, increasing to 8.00% after four years, and by an additional 2.00% annually thereafter up to a maximum of 12.00%.
- Conversion Price: Implied conversion price of $43.00 per share of Common Stock (initial conversion rate of 2.32558 shares).
- Transaction Costs: 3.0% commitment fee ($3.0 million) and up to $250,000 in reimbursable legal expenses.
- Use of Proceeds: General business, working capital, and potential future acquisitions.
Material Changes and Transaction Structure
The Company entered into an Investment Agreement with Maewyn XRN LP and other purchasers. The sale may occur in multiple tranches with a minimum initial funding request of $25.0 million, with the Initial Closing required on or prior to June 20, 2026. Additional funding requests may be made until November 6, 2026.
Key structural changes include:
- Board Representation: Maewyn XRN LP will nominate one director to the Board of Directors following the 2026 Annual Meeting.
- Standstill and Consent Rights: Maewyn XRN LP is subject to standstill restrictions but holds consent rights regarding new indebtedness (unless leverage remains below 0.60:1.00), REIT status revocation, and affiliate transactions.
- Warrants: Upon redemption of Series C Preferred Stock (after four years), holders may receive warrants to purchase Common Stock at the then-effective conversion price.
Guidance, Outlook, and Risks
Management intends to use proceeds for general corporate purposes and acquisitions. The filing does not provide specific financial guidance or revenue projections for the upcoming period.
Risks and Contingencies:
- Dilution: Conversion of preferred stock and exercise of warrants will increase the number of outstanding Common Shares, subject to a 19.9% beneficial ownership limitation until stockholder approval is obtained.
- Dividend Obligations: The Company is prohibited from paying dividends on Common Stock or repurchasing Junior Stock if Series C dividends are in arrears.
- Liquidity Conditions: Redemption and mandatory conversion are subject to specific Common Stock liquidity conditions and stockholder approval requirements.
Investor Verification Checklist
- Verify the exact timing and amount of the Initial Closing (minimum $25.0 million) scheduled by June 20, 2026.
- Confirm the impact of the 3.0% commitment fee and legal expenses on net proceeds.
- Review the specific terms of the "Common Stock Liquidity Conditions" required for redemption or mandatory conversion.
- Assess the dilution impact of the 1,000,000 shares of Series C Preferred Stock converting at $43.00 per share.
- Monitor the Company's leverage ratio to ensure it remains below 0.60:1.00 to avoid requiring Maewyn consent for new indebtedness.